These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1749020)
1. Antineoplastic dolastatins: potent inhibitors of hematopoietic progenitor cells. Jacobsen SE; Ruscetti FW; Longo DL; Keller JR J Natl Cancer Inst; 1991 Nov; 83(22):1672-7. PubMed ID: 1749020 [TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15. Beckwith M; Urba WJ; Longo DL J Natl Cancer Inst; 1993 Mar; 85(6):483-8. PubMed ID: 8445676 [TBL] [Abstract][Full Text] [Related]
3. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay. Aherne GW; Hardcastle A; Valenti M; Bryant A; Rogers P; Pettit GR; Srirangam JK; Kelland LR Cancer Chemother Pharmacol; 1996; 38(3):225-32. PubMed ID: 8646796 [TBL] [Abstract][Full Text] [Related]
4. Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells. Steube KG; Grunicke D; Pietsch T; Gignac SM; Pettit GR; Drexler HG Leukemia; 1992 Oct; 6(10):1048-53. PubMed ID: 1405759 [TBL] [Abstract][Full Text] [Related]
5. Effects of dolastatins on human B-lymphocytic leukemia cell lines. Hu ZB; Gignac SM; Quentmeier H; Pettit GR; Drexler HG Leuk Res; 1993 Apr; 17(4):333-9. PubMed ID: 8487581 [TBL] [Abstract][Full Text] [Related]
6. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma. Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072 [TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D; Strife A; Atzpodien J; Clarkson BD Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231 [TBL] [Abstract][Full Text] [Related]
8. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines. Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224 [TBL] [Abstract][Full Text] [Related]
9. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures. Jackson JD; Yan Y; Ewel C; Talmadge JE Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity. Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; LudueƱa RF; Hamel E Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072 [TBL] [Abstract][Full Text] [Related]
11. Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines. Blumenthal RD; Reising A; Leon E; Goldenberg DM Clin Cancer Res; 2002 May; 8(5):1301-9. PubMed ID: 12006552 [TBL] [Abstract][Full Text] [Related]
12. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Bai R; Pettit GR; Hamel E Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1. Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595 [TBL] [Abstract][Full Text] [Related]
14. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines. Ali MA; Rosati R; Pettit GR; Kalemkerian GP Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758 [TBL] [Abstract][Full Text] [Related]
15. Culture and characterization of hematopoietic progenitor cells from miniature swine. Emery DW; Sachs DH; LeGuern C Exp Hematol; 1996 Jul; 24(8):927-35. PubMed ID: 8690052 [TBL] [Abstract][Full Text] [Related]
16. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules. Bai R; Friedman SJ; Pettit GR; Hamel E Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820 [TBL] [Abstract][Full Text] [Related]
17. A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor. Bendel AE; Shao Y; Davies SM; Warman B; Yang CH; Waddick KG; Uckun FM; Perentesis JP Leuk Lymphoma; 1997 Apr; 25(3-4):257-70. PubMed ID: 9168436 [TBL] [Abstract][Full Text] [Related]
18. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells. Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636. Veiby OP; LoCastro S; Bhatnagar P; Olsen WM Stem Cells; 1996 Mar; 14(2):215-24. PubMed ID: 8991541 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]